Publication - Braun Lab

Dail M, Li Q, McDaniel A, Wong J, Akagi K, Huang B, Kang HC, Kogan SC, Shokat K, Wolff L, Braun BS, Shannon K.

Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage Leukemogenesis and modulate responses to targeted agents. Proc Natl Acad Sci USA 2010 Mar 16; 107(11):5106-11

Sabnis AJ, Cheung LS, Dail M, Kang HC, Santaguida M, Hermiston ML, Passegué E, Shannon K, Braun BS.

Oncogenic Kras initiates leukemia in hematopoietic stem cells PLoS Biol 2009 Mar 17;7(3):e59

Braun BS, Shannon K.

Targeting Ras in myeloid leukemias. Clin Cancer Res. 2008 Apr 15;14(8):2249-52.

Van Meter ME*, Díaz-Flores E*, Archard J, Passegué E, Irish JM, Kotecha N, Nolan GP, Shannon KM, Braun BS.

K-Ras^G12D Expression induces aberrant phosphorylation of multiple effectors in hematopoietic stem/progenitor cells. Blood 2007; 109: 3945-3952. * these authors contributed equally.

Braun BS, Archard JA, Van Ziffle JA, Tuveson DA, Jacks TE, Shannon K.
Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivo. Blood 2006; 108:2041-44

Zhang IH, Zane LT, Braun BS, Maize J Jr, Zoger S, Loh ML.

Congenital leukemia cutis with subsequent development of leukemia. J Am Acad Dermatol 54(2 Suppl):S22-7, 2006.

Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, Braun BS, Wang E, Kogan SC , Le Beau MM, Parada L, Shannon KM.

Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood 103(11):4243-50, 2004.

Braun BS, Tuveson DA, Kong N, Le DT, Kogan SC, Rozmus J, Le Beau MM, Jacks TE, and Shannon K.

Somatic Activation of Oncogenic Kras in Hematopoietic Cells Initiates a Rapidly Fatal Myeloproliferative Disorder. Proc Natl Acad Sci U S A 101(2):597-602, 2004.